This Longevity Genomics and Multi-Omics session explores genetic and multi-omics determinants of lifespan, healthspan, and resilience to age-related disease. Presentations will include genome-wide association studies, rare variant analyses, and studies of long-lived individuals and families. The track will feature integrative omics approaches—transcriptomics, proteomics, metabolomics, lipidomics, and single-cell analyses—to map aging trajectories and identify causal pathways. Methodological advances in data integration, network analysis, and causal inference will be discussed. Studies linking molecular signatures with clinical phenotypes, functional measures, and intervention responses are particularly welcome. The goal is to translate omics discoveries into mechanistically grounded targets and clinically usable risk and response stratification tools.
Title : Change your genes – Change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California School of Medicine, United States
Title : Improving mobility and health in over 45,000 humans using nanomedicine
Thomas J Webster, Brown University, United States
Title : An introduction to alchemical facial acupuncture: Sparking the shen
Mary Elizabeth Wakefield, Chi-Akra Center for Ageless Aging, United States
Title : Decoding the secret of longevity through big data: Noncoding RNAs—not proteins—drive animal lifespan evolution
Anyou Wang, DIFIBER LLC, United States
Title : Aspirin guided by coronary artery calcium scoring for primary prevention in persons with subclinical coronary heart disease
Arthur J Siegel, McLean Hospital, United States
Title : When BMI misleads: Integrating body composition, biomarkers, and personalized interventions for cardiometabolic healthspan in aging Asian and European cohorts
Narendra Kumar, HeartbeatsZ Academy, United Kingdom